What lessons have we learned in the past 40 years?

Stroke

Volumn 41, Issue 6, 2010, Pages 1073-1075

  Dyken, Mark L ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Lessons in stroke; Stroke care

Indexed keywords

CORTISONE; FIBRINOLYTIC AGENT; PLACEBO; WARFARIN;

ANALYTICAL ERROR; ANTICOAGULATION; BLEEDING; CLINICAL RESEARCH; CLINICAL TRIAL; CONSENSUS; DRUG EFFECT; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HUMAN; MEDICAL LITERATURE; MORTALITY; PRIORITY JOURNAL; PUBLISHING; RESEARCH ETHICS; RISK FACTOR; SHORT SURVEY; STROKE;

HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PERIODICALS AS TOPIC; STROKE;

EID: 77953167156     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.584011     Document Type: Short Survey

References (3)

1. Dyken M, White PT. Evaluation of cortisone in the treatment of cerebral infarction. JAMA. 1956;162:1531-1534.
2. Dorman PJ, Counsell C, Sandercock P. Reports of randomized trials in acute stroke, 1955 to 1995: What proportions were commercially sponsored? Stroke. 1999;30:1995-1998.
3. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzche, Lang T. for CONSORT Group. Revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663-694. (Pubitemid 32322245)